| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |